Concepedia

F Freytag

FF

3

Publications

117

Citations

3

H-Index

1997

Active since

Affiliations

Elisabeth-TweeSteden Ziekenhuis(Current)

F Freytag is an author at Elisabeth-TweeSteden Ziekenhuis specializing in pharmacotherapy, hypertension, and cardiovascular pharmacology.

Top concepts

Publications per year

1997–2002

3

Publications

3

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide

G. Hegner, G. Faust, F Freytag et al. · European Journal of Clinical Pharmacology · 1997 · 52 citations

, , +6

Comparison of 26-week efficacy and tolerability of telmisartan and atenolol, in combination with hydrochlorothiazide as required, in the treatment of mild to moderate hypertension: a randomized, multicenter study

F Freytag · Clinical Therapeutics · 2001 · 42 citations

, , +8

Long-term Exposure to Telmisartan as Monotherapy or Combination Therapy: Efficacy and Safety

F Freytag, Nicolaas J. Holwerda, Bengt E. Karlberg et al. · Blood Pressure · 2002 · 23 citations

Rows per page

1–3 of 3